Stock listing
GPW:URT Urteste S.A. Akcje
Follow Urteste S.A. into a list and get an email when it puts out news.
Share price · GPW:URT
51.20 PLN +5.20 (+11.3%)
Close on Nov 20, 2026
- Day range
- 46.00 – 52.80 PLNNov 20, 2026
- Volume
- 1,877 sharesNov 20, 2026
- Market cap
- 78.14M PLNAt the close on Nov 20, 2026 · price × 1.53M shares outstanding
- 52-week range
- 34.10 – 72.20 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 28,865 PLNMedian day 431 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:URT · PLN, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 51.20 | +5.20 | +11.3% | 50.40 | 52.80 | 46.00 | 1,877 | |
| 46.00 | +2.20 | +5.0% | 43.80 | 46.50 | 43.80 | 1,255 | |
| 43.80 | +0.80 | +1.9% | 43.00 | 44.00 | 43.00 | 257 | |
| 43.00 | 0.00 | 0.0% | 43.00 | 43.00 | 42.00 | 101 | |
| 43.00 | +0.80 | +1.9% | 41.80 | 44.60 | 41.10 | 780 | |
| 42.20 | +0.60 | +1.4% | 42.10 | 42.20 | 39.90 | 121 | |
| 41.60 | -0.60 | -1.4% | 41.60 | 42.20 | 41.60 | 125 | |
| 42.20 | +1.20 | +2.9% | 40.90 | 42.20 | 40.90 | 51 | |
| 41.00 | -1.20 | -2.8% | 40.00 | 41.00 | 39.90 | 1,431 | |
| 42.20 | +0.20 | +0.5% | 41.90 | 42.20 | 41.30 | 585 | |
| 42.00 | -0.10 | -0.2% | 42.20 | 42.20 | 41.90 | 111 | |
| 42.10 | 0.00 | 0.0% | 42.10 | 42.10 | 41.60 | 830 | |
| 42.10 | +1.10 | +2.7% | 42.00 | 42.10 | 42.00 | 4 | |
| 41.00 | -1.00 | -2.4% | 42.20 | 42.20 | 41.00 | 275 | |
| 42.00 | 0.00 | 0.0% | 42.60 | 42.60 | 40.80 | 152 | |
| 42.00 | -0.50 | -1.2% | 42.40 | 42.80 | 40.80 | 467 | |
| 42.50 | -0.30 | -0.7% | 42.10 | 42.70 | 41.90 | 808 | |
| 42.80 | +0.10 | +0.2% | 42.70 | 42.80 | 42.70 | 257 | |
| 42.70 | +1.30 | +3.1% | 42.00 | 42.90 | 42.00 | 214 | |
| 41.40 | -0.90 | -2.1% | 42.00 | 42.00 | 40.10 | 765 | |
| 42.30 | +0.50 | +1.2% | 41.90 | 42.30 | 41.50 | 205 | |
| 41.80 | -1.00 | -2.3% | 42.80 | 42.80 | 41.80 | 431 | |
| 42.80 | 0.00 | 0.0% | 42.00 | 42.80 | 42.00 | 291 | |
| 42.80 | +1.10 | +2.6% | 41.50 | 42.80 | 41.50 | 298 | |
| 41.70 | -1.10 | -2.6% | 42.90 | 42.90 | 41.70 | 143 | |
| 42.80 | 0.00 | 0.0% | 42.90 | 43.00 | 41.80 | 279 | |
| 42.80 | +0.10 | +0.2% | 42.70 | 43.50 | 42.00 | 93 | |
| 42.70 | 0.00 | 0.0% | 42.70 | 42.90 | 42.00 | 1,044 | |
| 42.70 | +0.10 | +0.2% | 41.50 | 42.70 | 41.50 | 413 | |
| 42.60 | -0.10 | -0.2% | 42.50 | 42.70 | 41.80 | 554 | |
| 42.70 | +0.50 | +1.2% | 42.20 | 42.90 | 41.40 | 854 | |
| 42.20 | +0.20 | +0.5% | 42.90 | 43.10 | 42.20 | 524 | |
| 42.00 | +0.20 | +0.5% | 42.70 | 43.10 | 40.60 | 1,361 | |
| 41.80 | -0.40 | -0.9% | 43.10 | 43.50 | 40.20 | 6,687 | |
| 42.20 | +0.20 | +0.5% | 41.50 | 42.20 | 41.00 | 358 | |
| 42.00 | 0.00 | 0.0% | 42.00 | 42.00 | 42.00 | 44 | |
| 42.00 | -0.20 | -0.5% | 42.20 | 42.20 | 41.50 | 44 | |
| 42.20 | -0.60 | -1.4% | 42.70 | 42.70 | 42.20 | 40 | |
| 42.80 | 0.00 | 0.0% | 42.80 | 42.80 | 42.80 | 1 | |
| 42.80 | +0.50 | +1.2% | 42.30 | 42.80 | 42.30 | 27 | |
| 42.30 | +0.50 | +1.2% | 42.40 | 42.80 | 41.30 | 48 | |
| 41.80 | -0.80 | -1.9% | 41.60 | 42.90 | 41.50 | 221 | |
| 42.60 | +0.60 | +1.4% | 41.10 | 43.40 | 41.10 | 1,417 | |
| 42.00 | -0.50 | -1.2% | 41.60 | 44.00 | 41.20 | 794 | |
| 42.50 | 0.00 | 0.0% | 42.40 | 42.50 | 40.60 | 233 | |
| 42.50 | -0.70 | -1.6% | 42.50 | 42.50 | 40.60 | 1,351 | |
| 43.20 | -0.80 | -1.8% | 43.50 | 43.50 | 42.00 | 517 | |
| 44.00 | +0.50 | +1.1% | 43.60 | 44.20 | 42.00 | 1,539 | |
| 43.50 | +1.00 | +2.4% | 43.30 | 43.80 | 42.50 | 265 | |
| 42.50 | -0.20 | -0.5% | 42.50 | 44.40 | 42.50 | 556 | |
| 42.70 | -0.30 | -0.7% | 43.10 | 43.10 | 40.80 | 77 | |
| 43.00 | +0.40 | +0.9% | 42.60 | 43.10 | 40.60 | 548 | |
| 42.60 | +0.30 | +0.7% | 42.40 | 42.60 | 41.00 | 273 | |
| 42.30 | +0.70 | +1.7% | 41.50 | 42.40 | 40.90 | 704 | |
| 41.60 | -1.40 | -3.3% | 42.10 | 43.00 | 41.60 | 433 | |
| 43.00 | -0.10 | -0.2% | 43.10 | 43.10 | 42.00 | 967 | |
| 43.10 | +0.10 | +0.2% | 42.00 | 43.10 | 42.00 | 570 | |
| 43.00 | 0.00 | 0.0% | 43.00 | 43.40 | 42.00 | 282 | |
| 43.00 | 0.00 | 0.0% | 44.10 | 44.10 | 43.00 | 512 | |
| 43.00 | -0.60 | -1.4% | 43.90 | 43.90 | 42.80 | 2,675 | |
| 43.60 | -0.10 | -0.2% | 43.80 | 43.80 | 42.90 | 1,027 | |
| 43.70 | +0.20 | +0.5% | 43.70 | 43.70 | 43.60 | 197 | |
| 43.50 | -0.30 | -0.7% | 43.00 | 43.80 | 43.00 | 1,495 | |
| 43.80 | +0.50 | +1.2% | 44.00 | 44.00 | 43.00 | 1,688 | |
| 43.30 | -0.20 | -0.5% | 44.40 | 44.40 | 43.30 | 1,068 |
- Ticker
- GPW:URT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- GPW
- Currency
- PLN
What changed lately
Latest news release · Jul 1, 2026
Urteste S.A. Receives U.S. Patent for the Panuri Test
Latest news
Urteste S.A. Receives U.S. Patent for the Panuri Test
Jul 1, 2026
Closed 47.80 (+0.4%) on Jul 1, 2026
Urteste S.A. enrolls the first patient in the Panuri test clinical study
Jun 10, 2026
Closed 44.30 (+4.5%) on Jun 10, 2026
Urteste S.A. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 2 in the last 12 months · 5 in all · newest Jul 1, 2026 · oldest 2024
Valuation
EV/sales 3,525× against a median of 2.9×: the highest of 9 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 77.55M PLN
- P/E
- Loss
- EV/sales
- 3,525×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 3.5×
- Gross margin
- Revenue too small
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Urteste S.A. · GPW:URT | US$19.24M | US$19.10M | n/a | 3,525× | n/a | 3.5× | n/a | 0.0× | n/a |
| IVIM Technology, Inc. · KRX:460470 | US$20.68M | US$10.37M | n/a | 2.1× | n/a | 1.1× | −40.9% | 0.0× | n/a |
| Q-linea AB · OMXSTO:QLINEA | US$20.66M | US$7.57M | n/a | 6.9× | n/a | 0.9× | n/a | 0.1× | n/a |
| TFBS Bioscience, Inc. · TPEX:6939 | US$19.81M | US$7.83M | n/a | 1.3× | n/a | 0.6× | −38.6% | 0.0× | n/a |
| SANIGEN Co., Ltd. · KRX:188260 | US$19.66M | US$10.06M | n/a | 2.2× | n/a | 2.3× | −82.6% | 0.1× | n/a |
| NanoRepro AG · XETR:NN6 | US$19.45M | US$11.45M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | n/a |
| Genematrix Inc. · KRX:109820 | US$19.06M | US$6.80M | n/a | 0.8× | 31.7× | 1.4× | −1.7% | 0.0× | n/a |
| Oxford BioDynamics PLC · LSE:OBD | US$18.46M | US$20.77M | n/a | 14.5× | n/a | 4.3× | n/a | 1.3× | n/a |
| RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S. · BIST:RTALB | US$18.41M | US$16.94M | 1.1× | 3.6× | 61.6× | 0.3× | 367.8% | 0.0× | n/a |
| Nexsen Limited · ASX:NXN | US$18.05M | US$15.08M | n/a | n/a | n/a | 4.8× | n/a | 0.0× | n/a |
| Genedrive PLC · LSE:GDR | US$17.85M | US$18.00M | n/a | 18.0× | n/a | n/a | −684.7% | n/a | n/a |
| Median of the others | US$19.25M | US$10.91M | 1.1× | 2.9× | 46.7× | 1.1× | −39.7% | 0.0× |
Team and board
Officers
| Officer | Role |
|---|---|
| Christian Pangratz | Chief Executive Officer |
Board
| Director | Role |
|---|---|
| Grzegorz Stefański | Member of the Board |
| Tomasz Kostuch | Member of the Board |
Financials
Annual, in PLN
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 22.0K | 1.80M | 1.33M | 3.00K | 0 | 0 | 0 |
| Cost of revenue | 322.0K | 298.0K | 479.0K | 291.0K | 116.6K | 14.8K | 30.4K |
| Gross profit | -322.0K | 1.50M | -479.0K | -288.0K | -116.6K | -14.8K | -30.4K |
| Research and development | 2.19M | 2.58M | 5.55M | 2.59M | 1.45M | 977.0K | |
| Selling, general and administrative | 865.0K | 969.0K | 1.22M | 1.38M | 1.35M | 565.9K | 254.5K |
| Operating income | -8.53M | -4.17M | -6.45M | -4.13M | -4.19M | -1.22M | -364.7K |
| Depreciation and amortization | 322.0K | 439.0K | 776.0K | 437.0K | 64.0K | 14.8K | 797 |
| EBITDA | -8.21M | -3.73M | -5.67M | -3.69M | -4.12M | -1.21M | -363.9K |
| Interest expense | 205.0K | 545.0K | 570.0K | 51.0K | 16 | 5.67K | 18 |
| Income before tax | -5.94M | -3.50M | -5.42M | -4.06M | -4.20M | -1.22M | -364.7K |
| Income tax | 44.0K | 128.0K | 162.0K | -378 | 19 | ||
| Net income | -5.98M | -3.63M | -5.59M | -4.06M | -2.32M | -530.2K | -364.7K |
| Earnings per share, basic | -4.24 | -2.58 | -4.32 | -3.58 | -2.21 | -0.89 | -0.61 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.84M | 1.46M | 1.14M | 3.43M | 8.53M | 427.3K | 173.3K |
| Short-term investments | 6.00M | 9.06M | 23.5M | ||||
| Receivables | 5.73M | 7.38M | 1.70M | 1.05M | 1.38K | 10.1K | |
| Inventory | 0 | 162.0K | 86.0K | 7.20K | 690.7K | 78 | |
| Current assets | 20.6M | 17.9M | 26.6M | 4.58M | 9.19M | 1.32M | 251.8K |
| Property, plant and equipment | 585.2K | 64.8K | |||||
| Total assets | 45.1M | 29.6M | 29.6M | 6.69M | 9.94M | 1.38M | 1.24M |
| Accounts payable | 312.0K | 841.0K | 371.0K | 415.0K | 230.0K | 8.90K | 38.5K |
| Current liabilities | 9.98M | 1.73M | 1.54M | 600.0K | 369.0K | 18.2K | 44.0K |
| Total debt | 2.98M | 415.0K | 627.0K | 597.0K | 710.0K | ||
| Total liabilities | 10.6M | 5.51M | 1.85M | 1.07M | 252.0K | 18.2K | 44.0K |
| Shareholders' equity | 24.9M | 24.1M | 27.7M | 5.62M | 9.69M | 674.3K | 1.20M |
| Shares outstanding | 1.41M | 1.41M | 1.29M | 1.14M | 1.05M | 595.2K | 595.2K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 10.6M | -5.47M | -5.32M | -3.79M | -2.57M | -1.35M | -398.5K |
| Capital spending | -231.0K | -8.96M | -1.74M | -1.19M | -656.4K | -42.2K | -38.3K |
| Free cash flow | 10.4M | -14.4M | -7.07M | -4.99M | -3.23M | -1.40M | -436.7K |
| Cash from investing | -9.41M | 6.23M | -24.4M | -1.19M | -656.4K | -42.2K | -38.3K |
| Cash from financing | 6.15M | -444.0K | 27.4M | -113.0K | 11.3M | 1.65M | 610.0K |
| Change in cash | 7.38M | 322.0K | -2.29M | -5.10M | 8.11M | 254.1K | 173.3K |
Cap table
Built by 6ix from Urteste S.A.’s releases
- Common shares
- 1,526,080
- Fully diluted
- 1,526,080
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,526,080 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,526,080 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Christian Pangratz | Chief Executive Officer · Since at least Nov 5, 2026 |
| Grzegorz Stefański | Member of the Board · Since at least Jul 1, 2026 |
| Tomasz Kostuch | Member of the Board · Since at least Jul 21, 2025 |
Log in to ask 6ix AI your own questions about Urteste S.A.